January 18, 2017

Ironshore Pharmaceuticals Completes US$200 Million Financing

Goodmans LLP represented Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., in the completion of a US$200 million private placement of Senior Secured Notes due 2024. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.

The proceeds from the financing will provide the necessary resources for Ironshore to complete its evolution from a research and development organization to a fully integrated pharmaceutical company with a world-class Medical Affairs function. The proceeds will also fund pre-commercialization marketing strategies and tactics as well as commercial launch activities for HLD200, a new drug that manages attention deficit hyperactivity disorder (ADHD) which is under review and awaiting approval by the U.S. Food and Drug Administration.

"Goodmans brings independence, governance expertise and deep capital markets knowledge to conflicts-sensitive mandates. Goodmans is consistently responsive and well-organised, and communicated clearly throughout." — Chambers Canada
"Goodmans brings a strong team to the table with a clear sense of pragmatism on highly complicated transactions." — Chambers Canada
"Goodmans capital markets team consistently delivers sound, practical advice with a sharp attention to detail on the granular nuances that matter in complex transactions." — Chambers Canada
"Goodmans has deep experience in capital markets and in the REIT space. Their service and responsiveness levels are also very high." — Chambers Canada
Goodmans LLP houses a full-service capital markets practice... Among its core strong suits, the group is arguably best known for its strength in SPACs, REITs and IPOs... — The Legal 500 Canada
"The team is very professional, solves problems efficiently and is very hard-working. It is a great pleasure and privilege to work with the team on cross-border transactions and multi-jurisdictional projects." — Legal 500 Canada
"It is one of our trusted and preferred legal firms when we go to select specific counsel. It is a leader in capital markets, and we trust the group's view and know that it works well." — Chambers Canada
A prominent player in REITs and SPAC-related offerings, also bearing an impressive record in cross-border and cannabis-related matters. — The Legal 500 Canada
Clients note, "They have an exceptional ability to understand the root of the issue and figure out realistic, step-by-step approaches to solve problems." — Chambers Canada
A distinguished practice valued for advising major REITs and financial institutions on innovative capital markets transactions. — Chambers Canada
On the Capital Markets group, one client says, "deep strength and expertise at all levels...nothing can replace stability and the fact that I have worked with Goodmans on both sides of the table since the early 2000’s." — Legal 500 Canada
One interviewee reported, "The Goodmans team as a whole is excellent," adding: "The lawyers are very responsive and get the job done. It is of great assurance to have them as our legal advisers." — Chambers Canada
Clients comment Goodmans Capital Markets team has "Deep experience, based upon decades of leadership in the sector." — IFLR1000
A client notes, "The lawyers that I have worked with at Goodmans are extremely professional, knowledgeable, creative and excellent service providers. The matters that we have worked on were extremely complicated and required high level of ability to combine understanding of our business objectives with legal analysis." — IFLR1000
Clients note the team's "institutional knowledge is very deep" and stated: "It's like they're part of the team they work with. They're extremely responsive." — Chambers Global

Practices

Industries

Ironshore Pharmaceuticals Completes US$200 Million Financing

Site Search

Ironshore Pharmaceuticals Completes US$200 Million Financing

Expertise

Featured Work